Evidence used
- No CISA KEV confirmation is currently recorded.
- A structured source references public exploit or proof-of-concept material.
- EPSS is 3.23% for the current model date.
BlackTreeCVE IntelligenceOpenClinica · OpenClinica
Official source article: GitHub GHSA-9RRV-PRFF-QPH7 ↗. Check the applicable product and release in the original source.
Medium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Medium technical severity with public exploit material referenced by a structured source; prioritise exposed affected systems while verifying vendor guidance.
Patch availableOpenClinica is an open source software for Electronic Data Capture (EDC) and Clinical Data Management (CDM). OpenClinica prior to version 3.16 is vulnerable to path traversal in multiple endpoints, leading to arbitrary file read/write, and potential remote code execution. There are no known workarounds. This issue has been patched and users are recommended to upgrade.
OpenClinica is an open source software for Electronic Data Capture (EDC) and Clinical Data Management (CDM). OpenClinica prior to version 3.16 is vulnerable to path traversal in multiple endpoints, leading to arbitrary file read/write, and potential remote code execution. There are no known workarounds. This issue has been patched and users are recommended to upgrade.
Attacker-controlled path data is not constrained to the intended directory before the application accesses a file.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may execute code or commands in the affected security context.
OpenClinica is an open source software for Electronic Data Capture (EDC) and Clinical Data Management (CDM). OpenClinica prior to version 3.16 is vulnerable to path traversal in multiple endpoints, leading to arbitrary file read/write, and potential remote code execution. There are no known workarounds. This issue has been patched and users are recommended to upgrade.
Attacker-controlled path data is not constrained to the intended directory before the application accesses a file.
An attacker operating through a network path may attempt exploitation with low privileges. If successful, the issue may execute code or commands in the affected security context.
CVSS severity, EPSS forecast probability, public exploit material and CISA-confirmed exploitation are separate signals.
No CISA KEV match was present at the last successful refresh. This means no confirmation from that source, not proof of no exploitation.
A structured CVE source labels at least one public reference as exploit material. BlackTree has not independently validated that it is safe, reliable or weaponised.
CWE-22: Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal'). The product uses external input to construct a pathname that is intended to identify a file or directory that is located underneath a restricted parent directory, but the product does not properly neutralize special elements within the pathname that can cause the pathname to resolve to a location that is outside of the restricted directory.
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:NCommon Vulnerability Scoring System 3.1: the compact vector below is decoded into plain language.
Operational remediation based on structured source evidence.
Published 13 May 2022 · Last source change 22 Apr 2025, 18:01 UTC · CWE-22 · Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')
Core structured fields are present and their contributing authorities are shown above.
No material field changes have been recorded since change tracking began. Routine source refreshes and cosmetic edits are intentionally excluded.